Moderate intensity training impact on the inflammatory status and glycemic profiles in NOD mice

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Codella, Roberto ^a,b,c   Lanzoni, Giacomo ^b   Zoso, Alessia ^b   Caumo, Andrea ^a,c   Montesano, Anna ^a   Terruzzi, Ileana M ^d   Ricordi, Camillo ^b   Luzi, Livio ^a,b,c   Inverardi, Luca ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL3 CHEMOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CCCL4 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; INTERLEUKIN-6, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDURANCE TRAINING; EXERCISE INTENSITY; FEMALE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MODERATE INTENSITY TRAINING; MOUSE; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; TREADMILL TEST; ANALYSIS; ANIMAL; BLOOD; CYTOLOGY; GENETICS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHEMOKINE CCL4; DIABETES MELLITUS, TYPE 1; FEMALE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN-SECRETING CELLS; INTERLEUKIN-6; MICE; MICE, INBRED NOD; PANCREAS; PHYSICAL CONDITIONING, ANIMAL;

EID: 84939613138     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/737586     Document Type: Article

References (39)

1. J. S. Skyler and C. Ricordi, "Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man," Diabetes, vol. 60, no. 1, pp. 1-8, 2011.
2. R. Bassi and P. Fiorina, "Impact of islet transplantation on diabetes complications and quality of life," Current Diabetes Reports, vol. 11, no. 5, pp. 355-363, 2011.
3. A.M. J. Shapiro, "State of the art of clinical islet transplantation and novel protocols of immunosuppression," Current Diabetes Reports, vol. 11, no. 5, pp. 345-354, 2011.
4. D. L. Souto and M. P. de Miranda, "Physical excercises on glycemic control in type 1 diabetes mellitus," Nutricion Hospitalaria, vol. 26, no. 3, pp. 425-429, 2011.
5. B. Zinman, N. Ruderman, B. N. Campaigne, J. T. Devlin, and S. H. Schneider, "Physical activity/exercise and diabetes mellitus," Diabetes Care, vol. 26, supplement 1, pp. S73-S77, 2003.
6. C. Tonoli, E. Heyman, B. Roelands et al., "Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis," Sports Medicine, vol. 42, no. 12, pp. 1059-1080, 2012.
7. A. N. Lumb and I. W. Gallen, "Diabetes management for intense exercise," Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 2, pp. 150-155, 2009.
8. J. E. Snyder-Cappione and B. S. Nikolajczyk, "When diet and exercise are not enough, think immunomodulation,"Molecular Aspects of Medicine, vol. 34, no. 1, pp. 30-38, 2013.
9. M. D. S. Krause and P. I. Homem De Bittencourt Jr., "Type 1 diabetes: can exercise impair the autoimmune event? The Larginine/ glutamine coupling hypothesis," Cell Biochemistry and Function, vol. 26, no. 4, pp. 406-433, 2008.
10. M. Orešič, S. Simell, M. Sysi-Aho et al., "Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes," The Journal of Experimental Medicine, vol. 205, no. 13, pp. 2975-2984, 2008.
11. G. I. Lancaster and M. A. Febbraio, "The immunomodulating role of exercise in metabolic disease," Trends in Immunology, vol. 35, no. 6, pp. 262-269, 2014.
12. F. C. Howarth, F. M. A. Marzouqi, A. M. S. Al Saeedi, R. S. Hameed, and E. Adeghate, "The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat," JOP, vol. 10,no. 5, pp.485-491, 2009.
13. O. Coskun, A.Ocakci, T. Bayraktaroglu, andM. Kanter, "Exercise training prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas," The Tohoku Journal of Experimental Medicine, vol. 203, no. 3, pp. 145-154, 2004.
14. M. S.Anderson and J. A. Bluestone, "TheNODmouse: a model of immune dysregulation," Annual Review of Immunology, vol. 23, pp. 447-485, 2005.
15. C. A. Aoki, A. T. Borchers, W. M. Ridgway, C. L. Keen, A. A. Ansari, and M. E. Gershwin, "NOD mice and autoimmunity," Autoimmunity Reviews, vol. 4, no. 6, pp. 373-379, 2005.
16. S. You, M.-A. Alyanakian, B. Segovia et al., "Immunoregulatory pathways controlling progression of autoimmunity in NOD mice," Annals of the New York Academy of Sciences, vol. 1150, pp. 300-310, 2008.
17. K. Buschard, "What causes type 1 diabetes? Lessons fromanimal models," APMIS, vol. 119, supplement s132, pp. 1-19, 2011.
18. D. C. Nieman and B. K. Pedersen, "Exercise and immune function. Recent developments," Sports Medicine, vol. 27, no. 2, pp. 73-80, 1999.
19. D. Keast, K. Cameron, and A. R. Morton, "Exercise and the immune response," Sports Medicine, vol. 5, no. 4, pp. 248-267, 1988.
20. A. Jayasimhan, K. P. Mansour, and R.M. Slattery, "Advances in our understanding of the pathophysiology of type 1 diabetes: lessons from the NOD mouse," Clinical Science, vol. 126, no. 1, pp. 1-18, 2014.
21. L. Hoffman-Goetz and B. K. Pedersen, "Exercise and the immune system: a model of the stress response?" Immunology Today, vol. 15, no. 8, pp. 382-387, 1994.
22. P. R. Galassetti, K. Iwanaga, M. Crisostomo, F. P. Zaldivar, J. Larson, and A. Pescatello, "Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls," Pediatric Diabetes, vol. 7, no. 1, pp. 16-24, 2006.
23. R. Brines, L. Hoffman-Goetz, and B. K. Pedersen, "Can you exercise to make your immune system fitter?" Immunology Today, vol. 17, no. 6, pp. 252-254, 1996.
24. P. M. Haahr, B. K. Pedersen, A. Fomsgaard et al., "Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma," International Journal of Sports Medicine, vol. 12, no. 2, pp. 223-227, 1991.
25. F. Zaldivar, J. Wang-Rodriguez, D. Nemet et al., "Constitutive pro-and anti-inflammatory cytokine and growth factor response to exercise in leukocytes," Journal of Applied Physiology, vol. 100, no. 4, pp. 1124-1133, 1985.
26. K. M. Beavers, T. E. Brinkley, and B. J.Nicklas, "Effect of exercise training on chronic inflammation," Clinica Chimica Acta, vol. 411, no. 11-12, pp. 785-793, 2010.
27. M. A. Atkinson and E. H. Leiter, "The NOD mouse model of type 1 diabetes: as good as it gets?" Nature Medicine, vol. 5, no. 6, pp. 601-604, 1999.
28. E. H. Leiter, "The NOD mouse: a model for insulin-dependent diabetes mellitus," Current Protocols in Immunology, chapter 15: unit 15.9, 2001.
29. H.-H. Huang, K. Farmer, J. Windscheffel et al., "Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice," Experimental Diabetes Research, vol. 2011, Article ID 481427, 10 pages, 2011.
30. J. B. Keller, W. C. Bevier, L. Jovanovic-Peterson, B. Formby, E. P. Durak, and C. M. Peterson, "Voluntary exercise improves glycemia in non-obese diabetic (NOD) mice," Diabetes Research and Clinical Practice, vol. 22, no. 1, pp. 29-35, 1993.
31. K. Becker-Zimmermann, M. Berger, P. Berchtold, F. A. Gries, L. Herberg, and M. Schwenen, "Treadmill training improves intravenous glucose tolerance and insulin sensitivity in fatty zucker rats," Diabetologia, vol. 22, no. 6, pp. 468-474, 1982.
32. M. Maris, G. B. Ferreira, W. D'Hertog et al., "High glucose induces dysfunction in insulin secretory cells by different pathways: a proteomic approach," Journal of Proteome Research, vol. 9, no. 12, pp. 6274-6287, 2010.
33. Z.-Q. Hou, H.-L. Li, L. Gao, L. Pan, J.-J. Zhao, and G.-W. Li, "Involvement of chronic stresses in rat islet and INS-1 cell glucotoxicity induced by intermittent high glucose," Molecular and Cellular Endocrinology, vol. 291, no. 1-2, pp. 71-78, 2008.
34. C. J. Mann, E. Ayuso, X. M. Anguela, and F. Bosch, "Skeletal muscle metabolism in the pathology and treatment of type 1 diabetes," Current Pharmaceutical Design, vol. 16, no. 8, pp. 1002-1020, 2010.
35. A. Jörns, T. Arndt, A. M. Zu Vilsendorf et al., "Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes," Diabetologia, vol. 57, no. 3, pp. 512-521, 2014.
36. A. Plesner, J. T. Ten Holder, and C. B. Verchere, "Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes," PLoS ONE, vol. 9, no. 8, Article ID e102843, 2014.
37. M. A. Atkinson, J. A. Bluestone, G. S. Eisenbarth et al., "How does type 1 diabetes develop?The notion of homicide or β-cell suicide revisited," Diabetes, vol. 60, no. 5, pp. 1370-1379, 2011.
38. B. O. Roep, M. Atkinson, and M. Von Herrath, "Satisfaction (not) guaranteed: re-evaluating the use of animalmodels of type 1 diabetes," Nature Reviews Immunology, vol. 4, no. 12, pp. 989-997, 2004.
39. A. Rabinovitch, "Animal models of type 1 diabetes are relevant to human IDDM-use caution," Diabetes/Metabolism Reviews, vol. 14, no. 2, pp. 189-190, 1998.